Wednesday, March 28, 2018 2:39:06 PM
EDGE:
Heard the call (all 10 minutes of it, 1/4 is safe harbor
) said drug performed as expected... the dread control arm much better than any past study or any data that they're aware of.
88 million cash at end of December burn 4-5m per month. Doing controlled shut down of the program and already laying off staff. Only other program is preclinical. They have 17+m debt though and from the K looks like 30+m shares. Probably should be a reverse merger but not a big enough discount to cash (for me) to speculate especially since don't know if management will try to keep things (their jobs) going a bit longer.
Heard the call (all 10 minutes of it, 1/4 is safe harbor
) said drug performed as expected... the dread control arm much better than any past study or any data that they're aware of. 88 million cash at end of December burn 4-5m per month. Doing controlled shut down of the program and already laying off staff. Only other program is preclinical. They have 17+m debt though and from the K looks like 30+m shares. Probably should be a reverse merger but not a big enough discount to cash (for me) to speculate especially since don't know if management will try to keep things (their jobs) going a bit longer.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
